Our Mission

Find (Diverse) KOLs & DOLs. Find Influential HCPs.

We empower biopharma and medical device companies with the best data and insights to select the key expert relationships that can accelerate treatment development and launch.

For Any Therapeutic Area and In Any Region

We work across all therapeutic areas with extensive experience in:

  • Rare Diseases

  • Oncology

  • Immunology

  • Gastroenterology

  • Metabolism

  • Endocrinology

  • Ophthalmology

  • Surgery

  • Psychiatry

  • Many more

We work across the globe, gathering data in:

  • North America

  • Europe

  • Latin America

  • Asia

  • Middle East

Leadership

Sandra Shpilberg

Co-Founder & CEO

Coby Shpilberg

Co-Founder & CTO

Team Members

Jennie Jacobson, PhD

Medical Director

Andrew Snyder

Project Manager

Mellisa Andrade

Reporting Manager

Arushi Talwar

Data Analyst

Austin Harrison

Data Analyst

Kimberly Wall

Finance

Pedro San Martino

Data Analyst

Delfina Kastelan

Data Analyst

How We Got Started

A long time ago, our Co-Founder, Sandra, was a product director at BioMarin Pharmaceutical. One of her first strategic tasks was to learn about the Key Opinion Leaders (KOLs) for a rare disease. Back then, she put together a lot of Excel spreadsheets and manually filled every box. This was a pain for sure, and the data was outdated the next time a KOL published a new paper. She tried to do her job as best she could, but the reality was that:

  • KOL discovery was slow and incomplete

  • There was no database to find complete profiles for these critical partners

  • There was no easy way to understand the collaboration networks already in place

  • The research was immediately outdated!

But first, Sandra took on another huge problem in the industry - finding patients for clinical trials. So, first, Sandra started and built Seeker Health. The company was sold to EVERSANA in late 2018. Fast forward to 2020 - the year the Covid pandemic started and her computer programmer son asked her the best question of all:

If you could build another company to solve a problem in biopharma, what would it be?

"I would build a company that solved the problem of finding KOLs efficiently, understanding their entire scientific history and how they collaborate with each other," she responded.

Enter Adnexi.

We use technology to dramatically improve the process of searching for KOLs and developing deep profiles. We map collaborations and influence. We operate across the globe. We work on any and all diseases and most importantly, we're helping leading biopharma companies accelerate the development of life-saving treatments.

It's nice to meet you! 👋🏼 We want to help you find the relationships that matter most in your disease of interest. We hope to work with you soon.